What is AbCellera Biologics Operating Cash Flow per Share?
AbCellera Biologics's operating cash flow per share for the
three
months ended in Mar. 2024 was $-0.14.
AbCellera Biologics's operating cash flow per share for the trailing twelve months (TTM) ended in Mar. 2024 was $-0.14.
During the past 12 months, the average Operating Cash Flow per Share Growth Rate of AbCellera Biologics was -128.00% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.
The historical rank and industry rank for AbCellera Biologics's Operating Cash Flow per Share or its related term are showing as below:
During the past 6 years, AbCellera Biologics's highest 3-Year average Operating Cash Flow per Share Growth Rate was 331.10% per year. The lowest was 271.30% per year. And the median was 301.20% per year.
ABCL's 3-Year OCF Growth Rate is not ranked *
in the Biotechnology industry.
Industry Median: 3.45 * Ranked among companies with meaningful 3-Year OCF Growth Rate only.
AbCellera Biologics Operating Cash Flow per Share Historical Data
The historical data trend for AbCellera Biologics's Operating Cash Flow per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
AbCellera Biologics Operating Cash Flow per Share Chart
Competitive Comparison of AbCellera Biologics's Operating Cash Flow per Share
For the Biotechnology subindustry, AbCellera Biologics's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
AbCellera Biologics's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, AbCellera Biologics's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where AbCellera Biologics's Price-to-Operating-Cash-Flow falls into.
AbCellera Biologics Operating Cash Flow per Share Calculation
Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.
AbCellera Biologics's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2023 is calculated as
Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.14
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AbCellera Biologics Operating Cash Flow per Share Related Terms
Thank you for viewing the detailed overview of AbCellera Biologics's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
AbCellera Biologics (AbCellera Biologics) Business Description
AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the most effective and developable leads fast and set partners up for enduring success. The company have extensive experience forging partnerships with emerging biotechs and leading pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ABCL has been successfully added to your 